VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Transurban Group vs Zimmer Biomet Holdings, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Transurban Group
TCL · Australian Securities Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Transurban Group's moat claims, evidence, and risks.
View TCL analysisZimmer Biomet Holdings, Inc.
ZBH · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Zimmer Biomet Holdings, Inc.'s moat claims, evidence, and risks.
View ZBH analysisComparison highlights
- Moat score gap: Transurban Group leads (91 / 100 vs 72 / 100 for Zimmer Biomet Holdings, Inc.).
- Segment focus: Transurban Group has 4 segments (49.5% in Sydney toll roads); Zimmer Biomet Holdings, Inc. has 4 segments (41.3% in Knees).
- Primary market structure: Quasi-Monopoly vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Transurban Group has 3 moat types across 3 domains; Zimmer Biomet Holdings, Inc. has 7 across 5.
Primary market context
Transurban Group
Sydney toll roads
Urban toll-road concessions (Sydney)
Sydney, New South Wales, Australia
Motorists and commercial fleet operators
Concessionaire / operator and developer
49.5%
Zimmer Biomet Holdings, Inc.
Knees
Knee reconstruction implants (primary, partial, revision) plus associated instruments and orthopedic robotics/navigation
Global
Hospitals and ambulatory surgery centers
OEM manufacturer
41.3%
Side-by-side metrics
Moat coverage
Shared moat types
Transurban Group strengths
Zimmer Biomet Holdings, Inc. strengths
Segment mix
Transurban Group segments
Full profile >Sydney toll roads
Quasi-Monopoly
Melbourne toll roads
Quasi-Monopoly
Brisbane toll roads
Quasi-Monopoly
North America managed lanes and concessions
Quasi-Monopoly
Zimmer Biomet Holdings, Inc. segments
Full profile >Knees
Oligopoly
Hips
Oligopoly
S.E.T. (Sports Medicine, Extremities, Trauma, CMFT)
Competitive
Technology & Data, Bone Cement and Surgical
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.